Clinical Trial Update: Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 preoperative study evaluating weekly paclitaxel and carboplatin with lapatinib (Tykerb) in ErbB2/HER2-positive Stage I–III breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)
• Tykerb (lapatinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: ErbB2-Positive Stage I-III Breast Cancer | Phase 2 | Status: UNKNOWN